Liver Failure

Therapies extend use of often-rejected livers for patient transplantation

Published in Hepatitis Weekly, June 24th, 2002

by Sonia Nichols, senior medical writer - Giving liver transplant recipients hepatitis B immune globulin and long-term antiviral therapy can allow them to receive transplanted livers from donors who are hepatitis B core antibody (HBcAb) positive without their developing hepatitis B virus (HBV) infection, university investigators suggest.

Based on a retrospective analysis of outcomes in the recipients of such livers, and contrary to common practice, researchers at Loyola University - Chicago, which is located in Chicago, Illinois, have proposed that using HBcAb positive liver grafts is okay, as long as certain therapies are also prescribed for the patient.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2002-06-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry